Atlas Trials

Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine

Clinical trial NCT04207385 · UNKNOWN

Trial details

NCT number
NCT04207385
Sponsor
Xijing Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Depression
Start date
2019-12-01
Primary completion
2021-08-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.